Get the Stockscreener App
4.49
0.45%
0.02
Sensus Healthcare Inc stock is traded at $4.49, with a volume of 75,309.
It is up +0.45% in the last 24 hours and down -2.18% over the past month.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
See More
Previous Close:
$4.47
Open:
$4.5
24h Volume:
75,309
Relative Volume:
0.32
Market Cap:
$71.43M
Revenue:
$24.41M
Net Income/Loss:
$485.00K
P/E Ratio:
7.8772
EPS:
0.57
Net Cash Flow:
$-2.37M
1W Performance:
+3.70%
1M Performance:
-2.18%
6M Performance:
-33.68%
1Y Performance:
+17.85%
1-Day Range:
$4.4591
$4.59
1-Week Range:
$4.01
$4.59
52-Week Range:
$4.01
$9.3293
Sensus Healthcare Inc Stock (SRTS) Company Profile
Name
Sensus Healthcare Inc
Sector
Industry
Phone
561-922-5808
Address
851 BROKEN SOUND PARKWAY NW, BOCA RATON, FL
Compare SRTS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SRTS
Sensus Healthcare Inc
|
4.49 | 71.43M | 24.41M | 485.00K | -2.37M | 0.57 |
|
ABT
Abbott Laboratories
|
133.24 | 231.09B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.86 | 155.24B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.92 | 144.54B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.48 | 108.82B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.68 | 44.31B | 5.54B | 4.18B | 623.10M | 7.00 |
Sensus Healthcare Inc Stock (SRTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-31-25 | Initiated | Lake Street | Buy |
| Nov-15-24 | Reiterated | Maxim Group | Buy |
| Feb-26-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Dec-16-20 | Downgrade | Northland Capital | Outperform → Market Perform |
| Aug-10-20 | Upgrade | Alliance Global Partners | Neutral → Buy |
| Feb-14-20 | Upgrade | Alliance Global Partners | Neutral → Buy |
| Nov-07-19 | Downgrade | B. Riley FBR | Buy → Neutral |
| Jan-29-19 | Downgrade | Northland Capital | Market Perform → Under Perform |
| Sep-26-18 | Initiated | B. Riley FBR | Buy |
| Nov-03-17 | Reiterated | Maxim Group | Buy |
| Jun-06-17 | Initiated | Maxim Group | Buy |
| Aug-08-16 | Initiated | Northland Capital | Outperform |
View All
Sensus Healthcare Inc Stock (SRTS) Latest News
Trading (SRTS) With Integrated Risk Controls - news.stocktradersdaily.com
3,898 Shares in Sensus Healthcare, Inc. (NASDAQ:SRTS) Bought by JPMorgan Chase & Co. - Defense World
Sensus Healthcare, Inc. (SRTS) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance
Why Sensus Healthcare, Inc. (NASDAQ:SRTS) Could Be Worth Watching - simplywall.st
Sensus Healthcare, Inc. (SRTS) Rises Yet Lags Behind Market: Some Facts Worth Knowing - MSN
Sensus Healthcare Celebrates Skin Cancer Awareness Month by Prom - GuruFocus
Sensus Healthcare, Inc. (SRTS) Outpaces Stock Market Gains: What You Should Know - Yahoo Finance
New Radiation Technology Treats Skin Cancer Without Surgery: Sensus Healthcare's Game-Changing Treatment - Stock Titan
Sensus Healthcare Celebrates Skin Cancer Awareness Month by Promoting Awareness and Spotlighting its Patient-Friendly, Non-Invasive Treatments - itemonline.com
Earnings Preview: Sensus Healthcare, Inc. (SRTS) Q1 Earnings Expected to Decline - Yahoo Finance
Sensus Healthcare to Report First Quarter 2025 Financial Results and Hold Business Update Conference Call on May 15 - Lelezard
Press Release Distribution & PR Platform - ACCESS Newswire
Is Sensus Healthcare (SRTS) a Buy as Wall Street Analysts Look Optimistic? - MSN
(SRTS) Trading Report - news.stocktradersdaily.com
Is Sensus Healthcare, Inc. (NASDAQ:SRTS) Potentially Undervalued? - Yahoo
Sensus Healthcare, Inc. (SRTS) Gains As Market Dips: What You Should Know - MSN
Sensus Healthcare, Inc. (SRTS) Increases Despite Market Slip: Here's What You Need to Know - MSN
Where are the Opportunities in (SRTS) - news.stocktradersdaily.com
HC Wainwright Reiterates “Buy” Rating for Sensus Healthcare (NASDAQ:SRTS) - Defense World
Declining Stock and Solid Fundamentals: Is The Market Wrong About Sensus Healthcare, Inc. (NASDAQ:SRTS)? - Yahoo
Sensus Healthcare, Inc. (SRTS) Rises As Market Takes a Dip: Key Facts - MSN
Is Sensus Healthcare Inc. (SRTS) the Popular Penny Stock on Robinhood to Watch? - Yahoo Finance
12 Popular Penny Stocks on Robinhood to Watch - Insider Monkey
Here's Why Sensus Healthcare, Inc. (SRTS) Gained But Lagged the Market Today - Yahoo Finance
Sensus Healthcare to Participate in the 37th Annual ROTH Conference - Joplin Globe
Medical Device Leader Sensus Healthcare Sets Key Investor Meetings at ROTH Conference - StockTitan
Investors Shouldn't Be Too Comfortable With Sensus Healthcare's (NASDAQ:SRTS) Earnings - Simply Wall St
Impressive Earnings May Not Tell The Whole Story For Sensus Healthcare (NASDAQ:SRTS) - Yahoo Finance
Lake Street Capital Issues Pessimistic Forecast for Sensus Healthcare (NASDAQ:SRTS) Stock Price - Defense World
Sensus Healthcare Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Brokers Suggest Investing in Sensus Healthcare (SRTS): Read This Before Placing a Bet - Nasdaq
Sensus Healthcare, Inc. to Host Earnings Call - ACCESS Newswire
Sensus Healthcare to Showcase Commercial and Late-Stage Products at the American Academy of Dermatology Annual Meeting - Joplin Globe
Can AI Transform Dermatology? Sensus Healthcare's Game-Changing Tech Debuts at Major Conference - StockTitan
IFP Advisors Inc Buys Shares of 13,700 Sensus Healthcare, Inc. (NASDAQ:SRTS) - Defense World
Sensus Healthcare, Inc. SEC 10-K Report - TradingView
Sensus Healthcare (NasdaqCM:SRTS) Shares Dip 14% After Q4 Earnings Show US$3 Million Net Income Drop - Yahoo Finance
Sensus Healthcare reports successful keloid treatment study - Investing.com
Sensus Healthcare reports successful keloid treatment study By Investing.com - Investing.com South Africa
Can This Radiation Therapy Finally Solve the Keloid Recurrence Problem? Taiwan Study Says Yes - StockTitan
Sensus Healthcare, Inc. (NASDAQ:SRTS) Stock's 27% Dive Might Signal An Opportunity But It Requires Some Scrutiny - Simply Wall St
Implied Volatility Surging for Sensus Healthcare (SRTS) Stock Options - MSN
How the (SRTS) price action is used to our Advantage - Stock Traders Daily
Sensus Healthcare announces sale of first SRT-100 Vision System to Asia - MSN
Sensus Healthcare Inc Stock (SRTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):